Byam Rebecca

Chief Financial Officer

1 company

Weak

Trades Analyzed

12M Win Rate

0.0%

Avg 3M Return

-13.0%

Avg 12M Return

-39.2%

Byam Rebecca is a Chief Financial Officer at HCW Biologics Inc.. Recent SEC Form 4 filings include 17 buys and 0 sells.

Estimated insider holdings value: $14K based on current market prices.

Holdings by Company

HCWBMay 8, 2025

Current Shares43.0K

Value$14.1K

Net Activity+494.7K

Bought: 494.7KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 8, 2025	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	8,462	$26.00	$220,012.00	+24.5%	-36.8%	-95.4%
Sep 13, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	5,000	$2.10	$10,490.00	+0.9%	-45.5%	-71.7%
Sep 12, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	10,000	$2.07	$20,715.00	+0.9%	-44.8%	-72.9%
Sep 8, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	10,000	$1.99	$19,853.00	+0.9%	-46.3%	-65.7%
Sep 6, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	5,000	$1.95	$9,749.00	+0.9%	-39.7%	-70.4%
Jun 9, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	20,000	$2.06	$41,286.00	+3.8%	-3.5%	-48.5%
Jun 8, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	24,696	$2.07	$51,019.55	+2.4%	-12.1%	-51.6%
Jun 6, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	39,062	$1.74	$68,122.62	+4.2%	+5.4%	-43.1%
May 26, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	40,000	$1.64	$65,544.00	+4.6%	+20.6%	-32.7%
May 24, 2023	HCWB Hcw Biologics Inc.	Chief Financial Officer	Buy	58,486	$1.56	$91,082.08	+5.1%	+22.3%	-31.0%